{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:09:13Z","timestamp":1776082153379,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08252-3","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:05:46Z","timestamp":1751907946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictive factors at initial visit for sunset glow fundus in Vogt\u2013Koyanagi\u2013Harada disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Tetsuya","family":"Muto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuju","family":"Sekiryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"8252_CR1","first-page":"e58867","volume":"16","author":"A Tayal","year":"2024","unstructured":"Tayal, A., Daigavane, S. & Gupta, N. Vogt\u2013Koyanagi\u2013Harada disease: A narrative review. Cureus 16, e58867 (2024).","journal-title":"Cureus"},{"key":"8252_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/bjophthalmol-2017-311691","volume":"103","author":"M Nakayama","year":"2019","unstructured":"Nakayama, M., Keino, H., Watanabe, T. & Okada, A. A. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt\u2013Koyanagi\u2013Harada disease treated with pulse intravenous corticosteroids. Br. J. Ophthalmol. 103, 274\u2013278 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"8252_CR3","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2147\/OPTH.S419546","volume":"17","author":"Y Hirota","year":"2023","unstructured":"Hirota, Y. et al. Association of retinal pigment epithelium reflectivity on optical coherence tomography with recurrence of Vogt\u2013Koyanagi\u2013Harada disease: A retrospective observational study. Clin. Ophthalmol. 17, 2071\u20132079 (2023).","journal-title":"Clin. Ophthalmol."},{"key":"8252_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3109\/09273948.2016.1139730","volume":"25","author":"AM Abu El-Asrar","year":"2017","unstructured":"Abu El-Asrar, A. M. et al. Chronic recurrent Vogt\u2013Koyanagi\u2013Harada disease and development of \u2018sunset glow fundus\u2019 predict worse retinal sensitivity. Ocul Immunol. Inflamm. 25, 475\u2013485 (2017).","journal-title":"Ocul Immunol. Inflamm."},{"key":"8252_CR5","doi-asserted-by":"publisher","first-page":"e0172612","DOI":"10.1371\/journal.pone.0172612","volume":"12","author":"K Hirooka","year":"2017","unstructured":"Hirooka, K. et al. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt\u2013Koyanagi\u2013Harada disease treated with systemic corticosteroids. PLoS One. 12, e0172612 (2017).","journal-title":"PLoS One"},{"key":"8252_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10792-017-0478-6","volume":"38","author":"A Hedayatfar","year":"2018","unstructured":"Hedayatfar, A. et al. The spectrum of Vogt\u2013Koyanagi\u2013Harada disease in Iran. Int. Ophthalmol. 38, 443\u2013449 (2018).","journal-title":"Int. Ophthalmol."},{"key":"8252_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12886-024-03511-9","volume":"24","author":"H Feng","year":"2024","unstructured":"Feng, H. et al. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt\u2013Koyanagi\u2013Harada disease. BMC Ophthalmol. 24, 238 (2024).","journal-title":"BMC Ophthalmol."},{"key":"8252_CR8","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3390\/jcm11133632","volume":"11","author":"M Accorinti","year":"2022","unstructured":"Accorinti, M. et al. Treatment and prognosis of Vogt\u2013Koyanagi\u2013Harada disease: Real-life experience in long-term follow-up. J. Clin. Med. 11, 3632 (2022).","journal-title":"J. Clin. Med."},{"key":"8252_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/aos.13189","volume":"95","author":"AM Abu El-Asrar","year":"2017","unstructured":"Abu El-Asrar, A. M., Dosari, M., Hemachandran, S., Gikandi, P. W. & Al\u2010Muammar, A. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of \u2018sunset glow fundus\u2019 in initial-onset acute uveitis associated with Vogt\u2013Koyanagi\u2013Harada disease. Acta Ophthalmol. 95, 85\u201390 (2017).","journal-title":"Acta Ophthalmol."},{"key":"8252_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10792-018-0949-4","volume":"39","author":"CP Herbort","year":"2019","unstructured":"Herbort, C. P. et al. Catching the therapeutic window of opportunity in early initial-onset Vogt\u2013Koyanagi\u2013Harada uveitis can cure the disease. Int. Ophthalmol. 39, 1419\u20131425 (2019).","journal-title":"Int. Ophthalmol."},{"key":"8252_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read, R. W. et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am. J. Ophthalmol. 131, 647\u2013652 (2001).","journal-title":"Am. J. Ophthalmol."},{"key":"8252_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamaophthalmol.2018.2664","volume":"136","author":"P Yang","year":"2018","unstructured":"Yang, P. et al. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 136, 1025\u20131031 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"8252_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/bjophthalmol-2014-306439","volume":"100","author":"Y Tagawa","year":"2016","unstructured":"Tagawa, Y. et al. Choroidal thickening prior to anterior recurrence in patients with Vogt\u2013Koyanagi\u2013Harada disease. Br. J. Ophthalmol. 100, 473\u2013477 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"8252_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10384-012-0128-5","volume":"56","author":"A Fujiwara","year":"2012","unstructured":"Fujiwara, A. et al. Enhanced depth imaging spectral-domain optical coherence tomography of subfoveal choroidal thickness in normal Japanese eyes. Jpn J. Ophthalmol. 56, 230\u2013235 (2012).","journal-title":"Jpn J. Ophthalmol."},{"key":"8252_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10384-022-00914-3","volume":"66","author":"Y Hamano","year":"2022","unstructured":"Hamano, Y. et al. Novel corneal morphological alterations in Vogt\u2013Koyanagi\u2013Harada disease. Jpn J. Ophthalmol. 66, 358\u2013364 (2022).","journal-title":"Jpn J. Ophthalmol."},{"key":"8252_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/1120672120902037","volume":"31","author":"T Muto","year":"2021","unstructured":"Muto, T. & Machida, S. Chronological changes of the anterior chamber structure, axial length, and refraction in patients with Vogt-Koyanagi-Harada disease. Eur. J. Ophthalmol. 31, 491\u2013496 (2021).","journal-title":"Eur. J. Ophthalmol."},{"key":"8252_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.oret.2017.07.016","volume":"2","author":"K Maruyama","year":"2018","unstructured":"Maruyama, K. et al. Predictors of recurrence in Vogt\u2013Koyanagi\u2013Harada disease. Ophthalmol. Retina. 2, 343\u2013350 (2018).","journal-title":"Ophthalmol. Retina"},{"key":"8252_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.ajo.2006.01.017","volume":"141","author":"H Keino","year":"2006","unstructured":"Keino, H., Goto, H., Mori, H., Iwasaki, T. & Usui, M. Association between severity of inflammation in CNS and development of sunset glow fundus in Vogt-Koyanagi-Harada disease. Am. J. Ophthalmol. 141, 1140\u20131142 (2006).","journal-title":"Am. J. Ophthalmol."},{"key":"8252_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajo.2024.01.035","volume":"262","author":"K Jin","year":"2024","unstructured":"Jin, K. et al. A novel risk stratification-based Immunomodulatory treatment strategy for Vogt\u2013Koyanagi\u2013Harada disease. Am. J. Ophthalmol. 262, 25\u201333 (2024).","journal-title":"Am. J. Ophthalmol."},{"key":"8252_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10384-015-0377-1","volume":"59","author":"C Iwahashi","year":"2015","unstructured":"Iwahashi, C. et al. Incidence and clinical features of recurrent Vogt\u2013Koyanagi\u2013Harada disease in Japanese individuals. Jpn J. Ophthalmol. 59, 157\u2013163 (2015).","journal-title":"Jpn J. Ophthalmol."},{"key":"8252_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/09273948.2019.1668430","volume":"29","author":"AF AlBloushi","year":"2021","unstructured":"AlBloushi, A. F. et al. Incidence, risk factors and surgical outcomes of cataract among patients with Vogt\u2013Koyanagi\u2013Harada disease. Ocul Immunol. Inflamm. 29, 128\u2013136 (2021).","journal-title":"Ocul Immunol. Inflamm."},{"key":"8252_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10384-021-00878-w","volume":"66","author":"T Ono","year":"2022","unstructured":"Ono, T. et al. Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt\u2013Koyanagi\u2013Harada disease. Jpn J. Ophthalmol. 66, 119\u2013129 (2022).","journal-title":"Jpn J. Ophthalmol."},{"key":"8252_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12348-023-00333-6","volume":"13","author":"N Rahman","year":"2023","unstructured":"Rahman, N. et al. Immunosuppressive therapy for Vogt\u2013Koyanagi\u2013Harada disease: A retrospective study and review of literature. J. Ophthalmic Inflamm. Infect. 13, 27 (2023).","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"8252_CR24","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1038\/s41467-023-39483-5","volume":"14","author":"Z Zhong","year":"2023","unstructured":"Zhong, Z. et al. A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt\u2013Koyanagi\u2013Harada disease. Nat. Commun. 14, 3768 (2023).","journal-title":"Nat. Commun."},{"key":"8252_CR25","first-page":"834","volume":"25","author":"L Xu","year":"2019","unstructured":"Xu, L. et al. PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Mol. Vis. 25, 834\u2013842 (2019).","journal-title":"Mol. Vis."},{"key":"8252_CR26","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1167\/iovs.13-12187","volume":"54","author":"C Zhang","year":"2013","unstructured":"Zhang, C. et al. MIF gene polymorphisms confer susceptibility to Vogt-Koyanagi- Harada syndrome in a Han Chinese population. Invest. Ophthalmol. Vis. Sci. 54, 7734\u20137738 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"8252_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00006982-199111030-00001","volume":"11","author":"J Beniz","year":"1991","unstructured":"Beniz, J., Forster, D. J., Lean, J. S., Smith, R. E. & Rao, N. A. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 11, 275\u2013280 (1991).","journal-title":"Retina"},{"key":"8252_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ophtha.2006.07.040","volume":"114","author":"P Yang","year":"2007","unstructured":"Yang, P. et al. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 114, 606\u2013614 (2007).","journal-title":"Ophthalmology"},{"key":"8252_CR29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00417-005-1146-5","volume":"244","author":"T Ueda","year":"2006","unstructured":"Ueda, T., Nawa, Y. & Hara, Y. Relationship between the retinal thickness of the macula and the difference in axial length. Graefes Arch. Clin. Exp. Ophthalmol. 244, 498\u2013501 (2006).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"8252_CR30","doi-asserted-by":"publisher","first-page":"13211","DOI":"10.1038\/s41598-024-63957-1","volume":"14","author":"T Muto","year":"2024","unstructured":"Muto, T. et al. Effect of the COVID-19 pandemic on Vogt\u2013Koyanagi\u2013Harada disease. Sci. Rep. 14, 13211 (2024).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08252-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:05:47Z","timestamp":1751907947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08252-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8252"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08252-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24302"}}